CA
BHC icon

Cullinan Associates’s Bausch Health BHC Stock Holding History

Cullinan Associates’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-47,800
Closed -$1.43M – 172
2019
Q4 		$1.43M Sell
47,800
-200
-0.4% -$5.2K 0.1% 118
2019
Q3 		$1.05M Buy
48,000
+967
+2% +$22.1K 0.07% 125
2019
Q2 		$1.19M Buy
47,033
+700
+2% +$16.6K 0.09% 121
2019
Q1 		$1.14M Buy
46,333
+100
+0.2% +$2.39K 0.09% 127
2018
Q4 		$854K Hold
46,233
– – 0.07% 129
2018
Q3 		$1.19M Buy
+46,233
New +$1.06M 0.09% 125

Other funds holding BHC

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cullinan Associates's BHC Position: Q1 2020 in Review

Cullinan Associates sold out of Bausch Health (BHC) in Q1 2020, closing a stake of 47,800 shares — an estimated $1.43M sold.

Cullinan Associates first reported a position in BHC in Q3 2018 and held it in 6 quarters. The position peaked at $1.43M in Q4 2019. 312 funds tracked by Wall St. Rank hold BHC as of Q1 2020.

  • Cullinan Associates reported no remaining Bausch Health position as of Q1 2020 after selling out during the quarter.
  • Cullinan Associates sold 47,800 Bausch Health shares in Q1 2020, an estimated $1.43M.
  • Cullinan Associates first reported a position in Bausch Health in Q3 2018 and held it in 6 quarters.
  • Cullinan Associates's Bausch Health position peaked at $1.43M in Q4 2019.
  • 312 funds tracked by Wall St. Rank held Bausch Health as of Q1 2020.

Based on Cullinan Associates's 13F filing for Q1 2020, filed 1 Apr 2020.